abstract |
The present disclosure provides, inter alia, methods for treating or ameliorating the effect of a cardiopulmonary disease, including right ventricular failure (RVF), in a subject. Also provided are methods for diagnosing the risk of having RVF in a subject, methods for preventing RVF in a subject, methods for preventing non-canonical autophagy, methods for mitigating oxidative stress in mitochondria of a cell, and methods for inhibiting microtubule-mediated active mRNA transfer in a cell. A pharmaceutical composition and treatment methods using such composition are also provided. |